The outlook of companies tied to Sildenafil's legacy presents a complex investment landscape. While the initial success generated substantial returns , generic copies have significantly impacted market share . Investing in related pharmaceutical businesses now requires a careful assessment of proprietary protection , evolving patient changes, and t